Screening for Postpartum Depression Using EPDS and HAM-D in Mothers Within 72 Hours After Delivery at a Tertiary Care Center (SOS-Mamma Study)
SOS-Mamma
Holistic Support Pathways for Maternal Psychological Wellbeing: A Comprehensive Approach From Preconception to Postpartum (SOS-Mamma).
1 other identifier
observational
273
1 country
1
Brief Summary
Postpartum depression (PPD) is one of the most common complications affecting maternal mental health after childbirth, with an estimated prevalence of 10-20% in high-income countries. Despite its frequency and the availability of effective screening tools, early diagnosis remains largely underestimated in routine clinical care. This study, part of the national SOS-Mamma project funded by the Italian Ministry of Health, aims to systematically screen for signs of postpartum depression in women giving birth at a tertiary care obstetric unit (AOU Vanvitelli - UOC of Obstetrics and Gynecology, Naples, Italy). The goal is to promote early detection and timely referral to specialized care pathways. The study is a prospective, observational, monocentric, non-interventional, non-pharmacological study. All eligible women who deliver at the hospital will be invited to participate within the first 72 hours after childbirth. Participants will be asked to complete the Edinburgh Postnatal Depression Scale (EPDS) - a widely used self-report questionnaire - and will undergo a brief clinical interview using the Hamilton Depression Rating Scale (HAM-D), conducted by trained healthcare staff. The study's primary objective is to estimate the real-world incidence of postpartum depression within this population. Secondary objectives include identifying socio-demographic and obstetric risk factors associated with depressive symptoms, assessing the acceptability and feasibility of routine screening, and contributing to the development of a replicable model of care aligned with international recommendations (NICE, WHO, ISS). Collected data will be anonymized and analyzed to provide evidence on early indicators of PPD and guide improvements in clinical care. Women identified as being at risk (e.g., EPDS \>10 or presence of suicidal ideation) will be referred to specialist psychiatric services in accordance with clinical guidelines. Participation in the study is voluntary. All procedures comply with European data protection regulations and Good Clinical Practice (GCP) principles. No experimental treatments are involved, and no changes to standard care will be made based on study participation. By highlighting the need for structured mental health screening in the postpartum period, this study hopes to improve maternal wellbeing and reduce the long-term impact of undiagnosed depression on mothers and their children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedStudy Start
First participant enrolled
July 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 18, 2025
June 1, 2025
12 months
June 9, 2025
June 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of postpartum depression assessed by EPDS
Incidence of postpartum depression assessed by EPDS The proportion of postpartum women who screen positive for depressive symptoms within 72 hours after delivery, based on the Edinburgh Postnatal Depression Scale (EPDS). The EPDS is a 10-item self-report questionnaire, and a score ≥10 is considered indicative of clinically relevant depressive symptoms.
Within 72 hours postpartum during routine hospital stay following delivery
Incidence of postpartum depression assessed by HAM-D
The proportion of postpartum women who screen positive for depressive symptoms within 72 hours after delivery, based on the Hamilton Depression Rating Scale (HAM-D). This clinician-administered scale assesses severity of depression; established cutoff scores will be used to classify presence of depressive symptoms.
Within 72 hours postpartum during routine hospital stay following delivery
Study Arms (1)
Postpartum Women Screened Within 72 Hours After Delivery
This cohort consists of postpartum women who deliver a live-born infant at ≥35 weeks of gestation and are clinically stable. Participants are screened within 72 hours after childbirth using the Edinburgh Postnatal Depression Scale (EPDS) and the Hamilton Depression Rating Scale (HAM-D). The study includes both women with and without depressive symptoms, allowing comparison within the cohort based on screening results. The purpose is to assess the incidence of postpartum depression and identify associated socio-demographic or obstetric risk factors in a real-world clinical setting
Interventions
Participants will undergo a standardized psychological screening protocol for postpartum depression within 72 hours after delivery. The protocol includes: (1) completion of the Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-administered questionnaire assessing depressive symptoms; and (2) administration of the Hamilton Depression Rating Scale (HAM-D), a 17-item clinician-administered tool for evaluating the severity of depressive symptoms. The combined use of these tools allows early detection and stratification of postpartum depressive symptoms in a clinical population.
Eligibility Criteria
The study population consists of postpartum women who deliver at the AOU Vanvitelli - UOC of Obstetrics and Gynecology, a tertiary care academic hospital in Naples, Italy. This is a real-world clinical population composed primarily of women receiving routine obstetric care through the Italian National Health System. The cohort includes patients with both physiological and low-risk obstetric complications. Participants will be recruited during their standard postpartum hospital stay, within 72 hours after delivery.
You may not qualify if:
- Multiple pregnancy (e.g., twins or higher-order gestations)
- Major psychiatric diagnosis under active treatment at the time of delivery (e.g., schizophrenia, bipolar disorder)
- Severe language barriers preventing adequate understanding of the consent form or questionnaires
- Neonatal death or congenital anomalies requiring prolonged NICU admission
- Maternal age \<18 or ≥45 years at delivery
- Gestational age at birth \<35 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Largo Madonna delle grazie 1
Naples, 80138, Italy
Related Publications (1)
Luciano M, Di Vincenzo M, Brandi C, Tretola L, Toricco R, Perris F, Volpicelli A, Torella M, La Verde M, Fiorillo A, Sampogna G. Does antenatal depression predict post-partum depression and obstetric complications? Results from a longitudinal, long-term, real-world study. Front Psychiatry. 2022 Dec 14;13:1082762. doi: 10.3389/fpsyt.2022.1082762. eCollection 2022.
PMID: 36590632RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., researcher and PhD student
Study Record Dates
First Submitted
June 9, 2025
First Posted
June 18, 2025
Study Start
July 15, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
June 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. The informed consent form signed by participants does not include provisions for data sharing outside the study team. Additionally, due to the sensitive nature of mental health data and the single-site observational design, sharing of IPD is not planned in order to ensure full compliance with ethical and data protection regulations (including GDPR).